NL8101026A - Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel. - Google Patents
Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel. Download PDFInfo
- Publication number
- NL8101026A NL8101026A NL8101026A NL8101026A NL8101026A NL 8101026 A NL8101026 A NL 8101026A NL 8101026 A NL8101026 A NL 8101026A NL 8101026 A NL8101026 A NL 8101026A NL 8101026 A NL8101026 A NL 8101026A
- Authority
- NL
- Netherlands
- Prior art keywords
- formula
- platinum
- group
- complex
- diamine complex
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 20
- 206010028980 Neoplasm Diseases 0.000 title claims description 12
- 201000011510 cancer Diseases 0.000 title claims description 11
- 229940126601 medicinal product Drugs 0.000 title 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims description 28
- 229910052697 platinum Inorganic materials 0.000 claims description 25
- -1 Platinum diamine Chemical class 0.000 claims description 20
- 150000001875 compounds Chemical class 0.000 claims description 17
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 6
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 5
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 4
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 150000007942 carboxylates Chemical group 0.000 claims description 4
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 3
- 229910052740 iodine Chemical group 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 125000000547 substituted alkyl group Chemical group 0.000 claims description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 claims description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical group OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 claims description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N nitrate group Chemical group [N+](=O)([O-])[O-] NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 claims description 2
- UPIXZLGONUBZLK-UHFFFAOYSA-N platinum Chemical class [Pt].[Pt] UPIXZLGONUBZLK-UHFFFAOYSA-N 0.000 claims 2
- DDRVFRXYTKAZHH-UHFFFAOYSA-N 2-carboxyoxycarbonylbenzoic acid Chemical group OC(=O)OC(=O)C1=CC=CC=C1C(O)=O DDRVFRXYTKAZHH-UHFFFAOYSA-N 0.000 claims 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 231100000417 nephrotoxicity Toxicity 0.000 description 5
- 239000007787 solid Substances 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002329 infrared spectrum Methods 0.000 description 3
- 231100001095 no nephrotoxicity Toxicity 0.000 description 3
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 208000028018 Lymphocytic leukaemia Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 208000003747 lymphoid leukemia Diseases 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- HRGDZIGMBDGFTC-UHFFFAOYSA-N platinum(2+) Chemical compound [Pt+2] HRGDZIGMBDGFTC-UHFFFAOYSA-N 0.000 description 2
- NDBYXKQCPYUOMI-UHFFFAOYSA-N platinum(4+) Chemical compound [Pt+4] NDBYXKQCPYUOMI-UHFFFAOYSA-N 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- QKHWUKPTSMULMZ-UHFFFAOYSA-N 2-(aminomethyl)-3,3,5-trimethylcyclopentan-1-amine Chemical compound CC1CC(C)(C)C(CN)C1N QKHWUKPTSMULMZ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 229910020427 K2PtCl4 Inorganic materials 0.000 description 1
- 208000006552 Lewis Lung Carcinoma Diseases 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940045985 antineoplastic platinum compound Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 150000003058 platinum compounds Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- GGHDAUPFEBTORZ-UHFFFAOYSA-N propane-1,1-diamine Chemical class CCC(N)N GGHDAUPFEBTORZ-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8101026A NL8101026A (nl) | 1981-03-03 | 1981-03-03 | Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel. |
US06/352,538 US4466924A (en) | 1981-03-03 | 1982-02-26 | Platinum-diamine complexes, a process for the preparation thereof, a process for the preparation of a medicine using such a platinum-diamine complex for the treatment of malignant tumors in mice as well as a medicine thus formed |
FR8203450A FR2501197A1 (fr) | 1981-03-03 | 1982-03-02 | Complexes de platine-diamine, procede d'obtention, application therapeutique et compositions pharmaceutiques contenant un tel complexe |
DE19823207472 DE3207472A1 (de) | 1981-03-03 | 1982-03-02 | Platin-diamin-komplexe, ein verfahren zu ihrer herstellung, ein verfahren zur herstellung eines arzneimittels unter einsatz eines derartigen platin-diamin-komplexes fuer die behandlung von krebs sowie das dabei erhaltene arzneimittel |
DK90382A DK90382A (da) | 1981-03-03 | 1982-03-02 | Platin-diamin-komlekser og fremgangsmaade til fremstilling deraf |
BE0/207447A BE892330A (nl) | 1981-03-03 | 1982-03-02 | Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel |
CA000397440A CA1172647A (en) | 1981-03-03 | 1982-03-02 | Platinum-diamine complexes, a process for the preparation thereof, a process for the preparation of a medicine using such a platinum-diamine complex for the treatment of cancer as well as a medicine thus formed |
JP57031851A JPS57163391A (en) | 1981-03-03 | 1982-03-02 | Platinum diamine complex, manufacture and use for treatment of cancer |
FI820737A FI71565C (fi) | 1981-03-03 | 1982-03-02 | Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara platinakomplex av 1-amino-2-aminometyl- 3,3,5-trimetylcyklopentan. |
CH1284/82A CH649985A5 (de) | 1981-03-03 | 1982-03-02 | Platin-diamin-komplexe, verfahren zu ihrer herstellung und sie enthaltende arzneimittel fuer die behandlung von krebs. |
AT0080182A AT377252B (de) | 1981-03-03 | 1982-03-02 | Verfahren zur herstellung von neuen platinkomplexen von 1-amino-2-aminomethyl-3,3,5trimethyl-cyclopentan |
LU83982A LU83982A1 (de) | 1981-03-03 | 1982-03-03 | Platin-diamin-komplexe,ein verfahren zu ihrer herstellung,ein verfahren zur herstellung eines arzneimittels unter einsatz eines derartigen platin-diamin-komplexes fuer die behandlung von krebs sowie das dabei erhaltene arzneimittel |
SE8201324A SE8201324L (sv) | 1981-03-03 | 1982-03-03 | Platinadiaminkomplex, forfarande for framstellning derav, forfarande for framstellning av ett lekemedel under anvendning av ett dylikt platinadiaminkomplex for behandling av cancer samt det pa sa sett framstellda lekeme |
IE480/82A IE52626B1 (en) | 1981-03-03 | 1982-03-03 | Platinum-diamine complexes,useful for the treatment of cancer |
YU459/82A YU42457B (en) | 1981-03-03 | 1982-03-03 | Process for obtaining platinum-diaminic complexes |
ZA821421A ZA821421B (en) | 1981-03-03 | 1982-03-03 | Platinum-diamine complexes,their preparation and use |
AU81091/82A AU559983B2 (en) | 1981-03-03 | 1982-03-03 | Platinum complexes, treatment of cancer |
IT19947/82A IT1150608B (it) | 1981-03-03 | 1982-03-03 | Complessi platino-diamminici e procedimento per la loro preparazione nonche' formulazioni farmaceutiche antitumorali contenenti tali complessi |
GB8206228A GB2093845B (en) | 1981-03-03 | 1982-03-03 | Platinum-diamine complexes useful for the treatment of cancer |
FI851548A FI76097C (fi) | 1981-03-03 | 1985-04-18 | Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara platina-diaminkomplex. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NL8101026 | 1981-03-03 | ||
NL8101026A NL8101026A (nl) | 1981-03-03 | 1981-03-03 | Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel. |
Publications (1)
Publication Number | Publication Date |
---|---|
NL8101026A true NL8101026A (nl) | 1982-10-01 |
Family
ID=19837101
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NL8101026A NL8101026A (nl) | 1981-03-03 | 1981-03-03 | Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel. |
Country Status (19)
Country | Link |
---|---|
US (1) | US4466924A (xx) |
JP (1) | JPS57163391A (xx) |
AT (1) | AT377252B (xx) |
AU (1) | AU559983B2 (xx) |
BE (1) | BE892330A (xx) |
CA (1) | CA1172647A (xx) |
CH (1) | CH649985A5 (xx) |
DE (1) | DE3207472A1 (xx) |
DK (1) | DK90382A (xx) |
FI (1) | FI71565C (xx) |
FR (1) | FR2501197A1 (xx) |
GB (1) | GB2093845B (xx) |
IE (1) | IE52626B1 (xx) |
IT (1) | IT1150608B (xx) |
LU (1) | LU83982A1 (xx) |
NL (1) | NL8101026A (xx) |
SE (1) | SE8201324L (xx) |
YU (1) | YU42457B (xx) |
ZA (1) | ZA821421B (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59112995A (ja) * | 1982-12-21 | 1984-06-29 | Shionogi & Co Ltd | 新規グリコ−ル酸白金錯体 |
JPS59222498A (ja) * | 1983-06-01 | 1984-12-14 | Shionogi & Co Ltd | 新規グリコ−ル酸系白金錯体および抗悪性腫瘍剤 |
JPS6087295A (ja) * | 1983-10-19 | 1985-05-16 | Nippon Kayaku Co Ltd | 新規白金錯体 |
US4599352A (en) * | 1984-03-01 | 1986-07-08 | The United States Of America As Represented By The Department Of Health And Human Services | Antineoplastic platinum (IV) complexes and compositions |
US4562275A (en) * | 1984-03-23 | 1985-12-31 | Bristol-Myers Co. | Antitumor platinum complexes |
US4550187A (en) * | 1984-04-12 | 1985-10-29 | The Research Foundation Of State University Of New York | Synthesis of platinum (IV) antineoplastic agents |
HU193809B (en) * | 1984-09-12 | 1987-12-28 | Chugai Pharmaceutical Co Ltd | Process for producing new platinum complexes |
US4739087A (en) * | 1985-01-10 | 1988-04-19 | Bristol-Myers Company | Antineoplastic platinum complexes |
US4737589A (en) * | 1985-08-27 | 1988-04-12 | Nippon Kayaku Kabushiki Kaisha | Platinum Complexes |
US4658047A (en) * | 1985-09-27 | 1987-04-14 | The United States Of America As Represented By The Department Of Health And Human Services | Method of preparing 1,2-diaminocyclohexane tetrachloro platinum (IV) isomers |
US5041581A (en) * | 1985-10-18 | 1991-08-20 | The University Of Texas System Board Of Regents | Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
GB8525689D0 (en) * | 1985-10-18 | 1985-11-20 | Johnson Mathey Plc | Platinum coordination compounds |
US5384127A (en) * | 1985-10-18 | 1995-01-24 | Board Of Regents, The University Of Texas System | Stable liposomal formulations of lipophilic platinum compounds |
US5117022A (en) * | 1985-10-18 | 1992-05-26 | The Board Of Regents, The University Of Texas System | Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
JPS62207283A (ja) * | 1986-03-07 | 1987-09-11 | Yoshinori Kitani | 新規な白金錯体 |
US4716157A (en) * | 1986-03-20 | 1987-12-29 | American Cyanamid Company | Heterocyclic-1,2-diamine platinum complexes |
JPS63203692A (ja) * | 1987-02-19 | 1988-08-23 | Nippon Kayaku Co Ltd | 新規白金錯体 |
US5072011A (en) * | 1988-02-02 | 1991-12-10 | Johnson Matthey, Inc. | Pt(IV) complexes |
ATE113054T1 (de) * | 1988-02-02 | 1994-11-15 | Johnson Matthey Inc | Pt(iv) komplexe. |
US5434256A (en) * | 1988-11-22 | 1995-07-18 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
US5393909A (en) * | 1988-11-22 | 1995-02-28 | Board Of Regents, The University Of Texas System | Diamine platinum complexes as antitumor agents |
US5041578A (en) * | 1988-11-22 | 1991-08-20 | Board Of Regents, The University Of Texas System | Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents |
US5196555A (en) * | 1989-10-17 | 1993-03-23 | Bristol-Myers Squibb Company | Water and solvent soluble axial hydroxy and mono- and di- carboxylic acid derivatives having high tumor activity |
US5843475A (en) | 1996-12-06 | 1998-12-01 | Board Of Regents, The University Of Texas System | Delivery and activation through liposome incorporation of diaminocyclohexane platinum (II) complexes |
EP1229934B1 (en) | 1999-10-01 | 2014-03-05 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1432562A (en) * | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum co-ordination compounds |
GB1578323A (en) * | 1976-02-26 | 1980-11-05 | Rustenburg Platinum Mines Ltd | Compositions containing platinum |
US4182724A (en) * | 1976-04-06 | 1980-01-08 | Rustenburg Platinum Mines Limited | Compositions containing platinum |
GB1585103A (en) * | 1976-04-06 | 1981-02-25 | Rustenburg Platinum Mines Ltd | Pharmaceutical compositions containing platinum compounds |
US4137248A (en) * | 1977-08-29 | 1979-01-30 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Compound, 4-carboxyphthalato(1,2-diaminocyclohexane)-platinum(II) and alkali metal salts thereof |
SE7903361L (sv) * | 1978-04-20 | 1979-10-21 | Johnson Matthey Co Ltd | Kompositioner innehallande platina |
SE7903359L (sv) * | 1978-04-20 | 1979-10-21 | Johnson Matthey Co Ltd | Kompositioner innehallande platina |
NL189358C (nl) * | 1978-07-06 | 1993-03-16 | Tno | Werkwijze voor het bereiden van een geneesmiddel voor de behandeling van kanker, alsmede een van een 1,3-alkaandiamine afgeleid platina-diamminecomplex. |
NL7807334A (nl) * | 1978-07-06 | 1980-01-08 | Tno | Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel. |
JPS6034958B2 (ja) * | 1978-09-02 | 1985-08-12 | 喜徳 喜谷 | 新規白金錯体 |
NL181434C (nl) * | 1980-01-03 | 1987-08-17 | Tno | Platina(iv)-diamine-complexen, alsmede hun bereiding en toepassing. |
-
1981
- 1981-03-03 NL NL8101026A patent/NL8101026A/nl not_active Application Discontinuation
-
1982
- 1982-02-26 US US06/352,538 patent/US4466924A/en not_active Expired - Fee Related
- 1982-03-02 DK DK90382A patent/DK90382A/da not_active Application Discontinuation
- 1982-03-02 BE BE0/207447A patent/BE892330A/nl not_active IP Right Cessation
- 1982-03-02 DE DE19823207472 patent/DE3207472A1/de not_active Ceased
- 1982-03-02 FR FR8203450A patent/FR2501197A1/fr active Granted
- 1982-03-02 JP JP57031851A patent/JPS57163391A/ja active Granted
- 1982-03-02 CA CA000397440A patent/CA1172647A/en not_active Expired
- 1982-03-02 AT AT0080182A patent/AT377252B/de not_active IP Right Cessation
- 1982-03-02 FI FI820737A patent/FI71565C/fi not_active IP Right Cessation
- 1982-03-02 CH CH1284/82A patent/CH649985A5/de not_active IP Right Cessation
- 1982-03-03 IT IT19947/82A patent/IT1150608B/it active
- 1982-03-03 SE SE8201324A patent/SE8201324L/ not_active Application Discontinuation
- 1982-03-03 LU LU83982A patent/LU83982A1/de unknown
- 1982-03-03 ZA ZA821421A patent/ZA821421B/xx unknown
- 1982-03-03 AU AU81091/82A patent/AU559983B2/en not_active Ceased
- 1982-03-03 YU YU459/82A patent/YU42457B/xx unknown
- 1982-03-03 IE IE480/82A patent/IE52626B1/en not_active IP Right Cessation
- 1982-03-03 GB GB8206228A patent/GB2093845B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
IT8219947A0 (it) | 1982-03-03 |
BE892330A (nl) | 1982-09-02 |
IT1150608B (it) | 1986-12-17 |
US4466924A (en) | 1984-08-21 |
IE820480L (en) | 1982-09-03 |
GB2093845B (en) | 1985-07-17 |
CH649985A5 (de) | 1985-06-28 |
FR2501197B1 (xx) | 1985-03-01 |
JPH0354117B2 (xx) | 1991-08-19 |
LU83982A1 (de) | 1982-07-08 |
YU42457B (en) | 1988-08-31 |
AU8109182A (en) | 1982-09-09 |
FI820737L (fi) | 1982-09-04 |
JPS57163391A (en) | 1982-10-07 |
IE52626B1 (en) | 1988-01-06 |
AU559983B2 (en) | 1987-03-26 |
CA1172647A (en) | 1984-08-14 |
DE3207472A1 (de) | 1982-09-16 |
GB2093845A (en) | 1982-09-08 |
FR2501197A1 (fr) | 1982-09-10 |
FI71565C (fi) | 1987-01-19 |
FI71565B (fi) | 1986-10-10 |
ATA80182A (de) | 1984-07-15 |
AT377252B (de) | 1985-02-25 |
DK90382A (da) | 1982-09-04 |
ZA821421B (en) | 1983-01-26 |
SE8201324L (sv) | 1982-09-04 |
YU45982A (en) | 1985-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL8101026A (nl) | Platinadiamine-complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platinadiamine-complex voor de behandeling van kanker alsmede aldus verkregen gevormd geneesmiddel. | |
FI72321B (fi) | Foerfarande foer framstaellning av nya vid behandling av cancer anvaendbara platina(iv)-diaminkomplexer | |
FI76350C (fi) | Foerfarande foer framstaellning av 2,2-substituerade 1,3-alkandiaminplatina(ii)-komplex med tumoerer hindrande aktivitet. | |
JPH0244838B2 (xx) | ||
HU224716B1 (en) | Platinum complex, its preparation and therapeutic application | |
HUT60747A (en) | Process for producing new trans-platinum compounds and pharmaceutical compositions comprising same as active ingredient | |
US4234500A (en) | Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes | |
KR910002536B1 (ko) | 플라티늄-디아민 착화물의 제조방법 | |
JPS6115892A (ja) | 抗腫瘍性白金化合物 | |
US4291027A (en) | Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes | |
HU203246B (en) | Process for producing antitumoural platinum(iv)-diamine complex and pharmaceutical compositions comprising such compound as active ingredient | |
FI76097C (fi) | Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara platina-diaminkomplex. | |
FI85861C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara komplexfoereningar. | |
FI83086C (fi) | Foerfarande foer framstaellning av komplex med tumormotverkande effekt. | |
JPS61249993A (ja) | 新規有機白金錯体及びその製法 | |
NL7904740A (nl) | Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmid- del met toepassing van een dergelijk platina-diamine- complex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel. | |
CA1219876A (en) | Bis(thiocyanato)palladium(ii) complexes | |
Kay | Platinum complexes for targeted drug delivery | |
NL8302115A (nl) | Platina-diamine complexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een geneesmiddel met toepassing van een dergelijk platina-diamine complex voor de behandeling van kanker, alsmede aldus verkregen gevormd geneesmiddel. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A1B | A search report has been drawn up | ||
A85 | Still pending on 85-01-01 | ||
BC | A request for examination has been filed | ||
BV | The patent application has lapsed |